Author Page for Masakazu Amari

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Risk Factors for Late Recurrence and Post-Relapse Survival in Estrogen Receptor (Er)Positive, Human Epidermal Growth Factor Receptor 2 (Her2)-Negative Breast Cancer after 5 Years of Endocrine Therapy

Number of pages: 24 Posted: 13 Jul 2023

Masahiro Ito, Masakazu Amari, Akiko Sato-Tadano, Masahiro Hikichi, Aru Sakamoto, Asumi Yamazaki and Shigehira Saji

affiliation not provided to SSRN, Tohoku University, Tohoku University - Graduate School of Medicine, affiliation not provided to SSRN, Tohoku University, Tohoku University and Fukushima Medical University

Downloads 55 (1,052,702)

View PDF
Download

Masakazu Amari

Tohoku University

1

55

0

Scholarly Papers (1)

Risk Factors for Late Recurrence and Post-Relapse Survival in Estrogen Receptor (Er)Positive, Human Epidermal Growth Factor Receptor 2 (Her2)-Negative Breast Cancer after 5 Years of Endocrine Therapy

Abstract: